SCI Pharmtech Inc (4119) — Cash Flow-to-Debt Ratio
SCI Pharmtech Inc (4119) has a Cash Flow-to-Debt Ratio of 0.04x as of December 2025, meaning its operating cash flow of NT$62.91 Million could theoretically repay 0% of its total liabilities (NT$1.49 Billion) in one year. See how much free cash does SCI Pharmtech Inc generate to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
SCI Pharmtech Inc Cash Flow-to-Debt Ratio (2002–2025)
Historical debt coverage capacity for SCI Pharmtech Inc across 23 annual periods. Also explore SCI Pharmtech Inc (4119) net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for SCI Pharmtech Inc (2002–2025)
Year-by-year debt coverage analysis for SCI Pharmtech Inc. For market capitalisation and broader financial context, see 4119 market cap.
| Year | CF-to-Debt Ratio | Operating CF (TWD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.15x | NT$220.32 Million | NT$1.49 Billion | ▼ -70.4% |
| 2024 | 0.50x | NT$860.52 Million | NT$1.72 Billion | ▲ +268.0% |
| 2023 | 0.14x | NT$215.77 Million | NT$1.59 Billion | ▼ -39.1% |
| 2022 | 0.22x | NT$296.56 Million | NT$1.33 Billion | ▼ -30.9% |
| 2021 | 0.32x | NT$280.28 Million | NT$869.26 Million | ▼ -58.6% |
| 2020 | 0.78x | NT$971.53 Million | NT$1.25 Billion | ▼ -40.3% |
| 2019 | 1.30x | NT$791.60 Million | NT$606.84 Million | ▲ +57.2% |
| 2018 | 0.83x | NT$480.18 Million | NT$578.85 Million | ▲ +7.8% |
| 2017 | 0.77x | NT$281.65 Million | NT$365.88 Million | ▼ -26.5% |
| 2016 | 1.05x | NT$502.11 Million | NT$479.43 Million | ▲ +9.7% |
| 2015 | 0.95x | NT$663.24 Million | NT$695.02 Million | ▲ +164.6% |
| 2014 | 0.36x | NT$358.77 Million | NT$994.64 Million | ▲ +48.9% |
| 2013 | 0.24x | NT$238.57 Million | NT$984.62 Million | ▼ -79.8% |
| 2012 | 1.20x | NT$385.57 Million | NT$321.12 Million | ▲ +85.4% |
| 2011 | 0.65x | NT$249.55 Million | NT$385.26 Million | ▲ +10.5% |
| 2010 | 0.59x | NT$218.96 Million | NT$373.37 Million | ▼ -60.3% |
| 2009 | 1.48x | NT$316.96 Million | NT$214.32 Million | ▲ +14.6% |
| 2008 | 1.29x | NT$245.29 Million | NT$190.16 Million | ▲ +36.1% |
| 2007 | 0.95x | NT$167.53 Million | NT$176.74 Million | ▼ -31.6% |
| 2006 | 1.39x | NT$131.62 Million | NT$94.94 Million | ▲ +133.5% |
| 2004 | 0.59x | NT$76.61 Million | NT$129.03 Million | ▼ -70.4% |
| 2003 | 2.01x | NT$206.86 Million | NT$102.99 Million | ▲ +383.3% |
| 2002 | 0.42x | NT$107.12 Million | NT$257.76 Million | — |